TCL1B protein, human
This gene is a member of the TCL1 gene family and acts as an oncogene, contributing to the uncontrolled proliferation of T-cells.
Understanding the functions and regulation of TCL1B is essential for developing effective targeted therapies and improving patient outcomes.
Researchers can leverage the power of PubCompare.ai to optimize their TCL1B protein research, enhanceing reproducibility and accuracy by identifying the most reliable and effective experimental protocols from literature, pre-prints, and patents.
Experiance the future of protein research today with this AI-powered platform.
Most cited protocols related to «TCL1B protein, human»
Most recents protocols related to «TCL1B protein, human»
Example 64
A 1:100 back-dilution from overnight culture of SYN-PKU-2002 was grown to early log phase for 1.5 h before moving to the anaerobic chamber for 4 hours in the presence of 1 mM IPTG and 0.1% arabinose for induction as described herein. To perform activity assay, 1e8 cells were resuspended and incubated in assay buffer (M9 media with 0.5% glucose, 50 mM Phe, and 50 mM MOPS with 50 mM phenylalanine). Supernatant samples were taken over time and TCA (the product of PAL) was measured by absorbance at 290 nm to determine the rate of TCA production/PAL activity. Phenylpyruvate was measured using LCMS methods described herein. Results are shown in FIG. 16A and FIG. 16B.
Example 8
Ceftriaxone (at 3 ug/ml or 1500 ug/ml) was mixed with human intestinal chyme alone, or with chyme plus SYN-004 (8 ug/ml) or with chyme plus the beta-lactamase inhibitor sulbactam, (20 mg/ml) or chyme plus both and then the samples were flash frozen. The flash frozen samples were thawed on ice and sulbactam was added to some samples, the protein was precipitated with acetonitrile and the samples were analyzed for ceftriaxone concentration by LC/MS-MS. The table below provides results from triplicate samples.
Even at 20 mg/ml Sulbactam, 8 ug/ml of SYN-004 could not be inhibited (that's a molar ratio of about 287,000:1, sulbactam to SYN-004). Altogether, these data suggested that Sulbactam did not substantially inhibit SYN-004 activity in intestinal chyme.
Protocol full text hidden due to copyright restrictions
Open the protocol to access the free full text link